A global analysis spanning 194 countries reveals a mixed picture for newborn survival: deaths caused by birth asphyxia, trauma, and prematurity have declined markedly since 2000, yet progress is slowing in many low- and middle-income countries, particularly across sub-Saharan Africa.

25 Jun 2026

Strategic healthcare interventions bring Japan close to eliminating hepatitis

Hepatitis B (HBV) and hepatitis C (HCV) are viral infections that can lead to health conditions such as cirrhosis, cancer, and potentially death if unmanaged. HBV can be transmitted through sexual contact, blood exposure, and mother-to-child transmission, while HCV is primarily transmitted through blood-to-blood contact.

25 Jun 2026

High-dose DHA reaches the brain but fails to protect memory

High-dose DHA effectively increased brain levels in older adults at Alzheimer's risk, but did not lead to cognitive or structural brain health improvements.

25 Jun 2026

Blueberries may boost children's memory and mood

Research suggests blueberry compounds could enhance mood and cognitive function in children, yet stronger evidence is required for clinical recommendations.

25 Jun 2026

European project receives €15 million to study phage-based therapies

Bacteria are becoming increasingly resistant to antibiotics. One alternative is treatment with viruses that exclusively infect bacteria, known as phages.

25 Jun 2026

Merck Kgaa, Darmstadt, Germany, agrees to acquire Bio-Techne, strengthening leadership position in fast-growing life sciences markets

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive agreement pursuant to which Merck KGaA, Darmstadt, Germany, will, subject to customary closing conditions, acquire Bio-Techne for US$73 per share in cash, representing a total enterprise value of approximately US$11.3 billion (EUR 9.9 billion), a 36% premium to Bio-Techne's one-month volume weighted average trading price.

From Bio-Techne 25 Jun 2026

Welbeck Health Partners adopts OMED Health’s home-based SIBO testing pathway across its network

OMED Health ("OMED"), part of Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, and Welbeck Health Partners ("Welbeck"), one of the UK's largest specialist outpatient healthcare providers, today announced that Welbeck has adopted OMED Health's home-based Small Intestinal Bacterial Overgrowth (SIBO) breath-testing pathway. The roll out across Welbeck's network follows a three-month evaluation where the pathway was assessed for performance and impact on standard of care.

From Welbeck Health Partners 25 Jun 2026

Study shows unequal access to specialized chronic pain rehabilitation

Patients with chronic pain do not have access to specialized rehabilitation on equal terms. Education, age, sex, and region of birth appear to play a role, particularly in combination, according to a Sweden-based study from the University of Gothenburg.

25 Jun 2026

Scientists map blood chemistry links to hundreds of diseases

A UK Biobank study of nearly 390,000 people mapped 251 NMR-derived plasma metabolic traits against hundreds of health traits, prevalent diseases, and future disease outcomes. The atlas revealed tens of thousands of replicated associations, showed stronger prediction for selected short-term and cardiometabolic outcomes, and identified putative causal links that may guide future precision medicine research.

24 Jun 2026

England faces widening obesity inequalities across regions and communities

This study is the first to analyse obesity trends from 2019 to 2025, using NHS England electronic health records covering nearly 55 million adults.

24 Jun 2026

Study links COVID-19 to higher sleep apnea risk years after infection

Researchers analyzed more than 910,000 adults and found that SARS-CoV-2 infection was associated with a higher adjusted risk of new-onset obstructive sleep apnea up to 4.5 years later. The association appeared in both hospitalized and non-hospitalized COVID-19 patients, supporting targeted screening in higher-risk post-COVID groups while highlighting the need for objective sleep testing.

24 Jun 2026

Socioeconomic factors alter patient experiences during lung cancer screening

New research among lung cancer screening participants has found that low-dose chest computed tomography (CT) screening is generally well tolerated both physically and emotionally, but experiences vary across socioeconomic groups.

24 Jun 2026

Open source tool automates data reanalysis to detect rare diseases

A newly developed open-source tool designed for rigorous reanalysis of genomic data is highly effective at detecting new rare disease diagnoses.

24 Jun 2026

Study compares menopause symptom burden across different age groups

There has been a lot of discussion about how the age at menopause can affect menopause symptoms. A new study compared the prevalence and severity of menopause symptoms in women experiencing menopause around the average age of 51 years and those with premature ovarian insufficiency, showing similar symptom burden in the psychological and urogenital domains.

24 Jun 2026

Hidden costs push United States dementia toll to historic high

A new USC-led study finds Alzheimer's disease and related dementias will cost the United States an estimated $818 billion this year, driven largely by often-overlooked costs to persons living with dementia and family and friends providing their care.

24 Jun 2026

New pathway speeds up biliary atresia diagnosis in newborns

BA is difficult to detect because early jaundice can resemble common newborn conditions, and pale stools may not appear immediately.

24 Jun 2026

A window into the body – Occuity harnesses Renishaw encoders in life-changing optical health screening devices

Throughout the world, the diagnosis and treatment of systemic disease present major health challenges.

From Occuity 24 Jun 2026

Plant-based Mediterranean-style diet cuts heart disease risk by 26%

A 20-year study links plant-based Mediterranean diets to lower heart disease risk, highlighting the importance of sustainable eating for cardiovascular health.

24 Jun 2026

Faster biological aging may explain rising early-onset cancers

The link between biological aging and early-onset cancer risk offers crucial insights into generational health trends and potential preventive measures.

24 Jun 2026

Human-AI teams improve healthcare only when clinicians stay in control

A scoping review of 140 empirical studies found that human-AI collaboration in healthcare reports the most consistent benefits in diagnostic interpretation, especially when AI supports bounded tasks and clinicians retain final responsibility. Evidence remains fragmented across triage, treatment planning, and documentation, with few studies measuring patient outcomes, system impact, trust calibration, or governance in real-world settings.

24 Jun 2026